Platelet glycoprotein Ibα provides radiation protection. (February 2022)
- Record Type:
- Journal Article
- Title:
- Platelet glycoprotein Ibα provides radiation protection. (February 2022)
- Main Title:
- Platelet glycoprotein Ibα provides radiation protection
- Authors:
- Corken, Adam
Ghosh, Sanchita P.
Du, Ruofei
Boerma, Marjan
Ware, Jerry
Pathak, Rupak - Abstract:
- Highlights: Platelet glycoprotein Ibα (GPIbα) dysfunction enhances radiation lethality in mice. GPIbα dysfunction reduces platelet–leukocyte aggregation before/after irradiation. GPIbα dysfunction increases monocyte activation and gut damage following radiation. GPIbα dysfunction increases serum cytokine levels following radiation. Abstract: Background and Purpose: Platelet membrane glycoprotein Ibα (GPIbα), the major ligand-binding subunit of the GPIb-IX–V complex, binds to a number of ligands contributing to hemostasis, thrombosis, and inflammation. Binding to von Willebrand factor (VWF) initiates the process of hemostasis/thrombosis, while binding to the leukocyte receptor Macrophage-1 antigen (Mac-1) has been implicated in modulating the inflammatory response. Thus as GPIbα resides at the nexus of thrombosis and inflammation, we investigated the impact of GPIbα on radiation injury outcomes as this injury triggers both the thrombotic and inflammatory pathways. Materials and Methods: We used wild-type (WT) C57BL/6J mice and a dysfunctional GPIbα mouse model, in which endogenous GPIbα is replaced with a non-functional α-subunit (hIL-4R/Ibα), to determine whether the impairment of platelet GPIbα alters radiation response. Following exposure to 8.5 Gy total body irradiation (TBI), a series of parameters including radiation lethality, platelet–neutrophil/monocyte interactions, neutrophil/monocyte activation, serum cytokine levels and intestinal injury, were compared betweenHighlights: Platelet glycoprotein Ibα (GPIbα) dysfunction enhances radiation lethality in mice. GPIbα dysfunction reduces platelet–leukocyte aggregation before/after irradiation. GPIbα dysfunction increases monocyte activation and gut damage following radiation. GPIbα dysfunction increases serum cytokine levels following radiation. Abstract: Background and Purpose: Platelet membrane glycoprotein Ibα (GPIbα), the major ligand-binding subunit of the GPIb-IX–V complex, binds to a number of ligands contributing to hemostasis, thrombosis, and inflammation. Binding to von Willebrand factor (VWF) initiates the process of hemostasis/thrombosis, while binding to the leukocyte receptor Macrophage-1 antigen (Mac-1) has been implicated in modulating the inflammatory response. Thus as GPIbα resides at the nexus of thrombosis and inflammation, we investigated the impact of GPIbα on radiation injury outcomes as this injury triggers both the thrombotic and inflammatory pathways. Materials and Methods: We used wild-type (WT) C57BL/6J mice and a dysfunctional GPIbα mouse model, in which endogenous GPIbα is replaced with a non-functional α-subunit (hIL-4R/Ibα), to determine whether the impairment of platelet GPIbα alters radiation response. Following exposure to 8.5 Gy total body irradiation (TBI), a series of parameters including radiation lethality, platelet–neutrophil/monocyte interactions, neutrophil/monocyte activation, serum cytokine levels and intestinal injury, were compared between the strains. Results: The lack of functional GPIbα resulted in higher radiation lethality, greater monocyte activation, increased levels of serum pro-inflammatory cytokines, heightened intestinal damage, and a reduction of intestinal neutrophil recovery. Conclusion: These data suggest that loss of platelet GPIbα enhances radiation toxicity and that GPIbα-mediated interactions may play a crucial role in limiting radiation damage. Thus, a mechanistic understanding of the biological impact of GPIbα following TBI could provide crucial insights for improving the safety of radiotherapy and minimizing the deleterious effects of accidental or occupational exposure to high-dose radiation. … (more)
- Is Part Of:
- Radiotherapy and oncology. Volume 167(2022)
- Journal:
- Radiotherapy and oncology
- Issue:
- Volume 167(2022)
- Issue Display:
- Volume 167, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 167
- Issue:
- 2022
- Issue Sort Value:
- 2022-0167-2022-0000
- Page Start:
- 143
- Page End:
- 148
- Publication Date:
- 2022-02
- Subjects:
- CD Cluster of differentiation -- GP Glycoprotein -- IL Interleukin -- IR Ionizing radiation -- KC Keratinocyte chemoattractant -- Mac-1 Macrophage-1 antigen -- MCP-1 Monocyte Chemoattractant Protein 1 -- MFI Mean fluorescence intensity -- MIP-1β Macrophage inflammatory protein-1β -- MSA Mucosal surface area -- SEM Standard error of the mean -- TBI Total body irradiation -- TNFα Tumor necrosis factor alpha -- TPO Thrombopoietin -- VWF von Willebrand factor -- WT Wild type
Platelets -- Radiation -- Inflammation -- Intestines -- Leukocytes
Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗ - DOI:
- 10.1016/j.radonc.2021.12.030 ↗
- Languages:
- English
- ISSNs:
- 0167-8140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21050.xml